Progress of immune cell therapy in hematological malignancies
10.3760/cma.j.cn115356-20240925-00147
- VernacularTitle:免疫细胞疗法在恶性血液肿瘤中的研究进展
- Author:
Zhongyu WANG
1
;
Zengzheng LI
;
Yifan HE
;
Yajie WANG
Author Information
1. 昆明理工大学医学院，昆明 650032
- Keywords:
Hematologic neoplasms;
Immune cell therapy;
Chimeric antigen receptor T-cell;
Cytokine-induced killer cells
- From:
Journal of Leukemia & Lymphoma
2025;34(7):442-445
- CountryChina
- Language:Chinese
-
Abstract:
Hematological malignancies are a serious disease with a high risk of mortality and a high tendency to recur. The current mainstream treatment methods mainly include chemotherapy, targeted therapy, supportive therapy, and hematopoietic stem cell transplantation. Immune cell therapy can induce the function of immune cells and accurately kill tumors and pathogens. For those refractory patients who experience relapse or have poor response to traditional treatments, the immune cell therapy has good clinical efficacy. This article reviews the latest advances in immune cell therapy for hematological malignancies.
